Dexco SA (BSP:DXCO3, Financial) is set to release its Q3 2024 earnings on Nov 6, 2024. The consensus estimate for Q3 2024 revenue is $2.01 billion, and the earnings are expected to come in at $0.17 per share. The full year 2024's revenue is expected to be $7.81 billion and the earnings are expected to be $0.36 per share. More detailed estimate data can be found on the Forecast page.
Dexco SA (BSP:DXCO3, Financial) Estimate Trends
Over the past 90 days, revenue estimates for Dexco SA (BSP:DXCO3) have seen an increase from $7.77 billion to $7.81 billion for the full year 2024, and from $8.19 billion to $8.27 billion for 2025. Earnings estimates for the full year 2024 have been revised downward from $0.37 per share to $0.36 per share, while the estimates for 2025 have been revised upward from $0.41 per share to $0.59 per share.
Dexco SA (BSP:DXCO3, Financial) Reported History
In the previous quarter of 2024-06-30, Dexco SA's (BSP:DXCO3) actual revenue was $1.99 billion, which beat analysts' revenue expectations of $1.97 billion by 1.48%. Dexco SA's (BSP:DXCO3) actual earnings were $0.12 per share, which met analysts' earnings expectations. After releasing the results, Dexco SA (BSP:DXCO3) was up by 5.56% in one day.
Dexco SA (BSP:DXCO3, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 5 analysts, the average target price for Dexco SA (BSP:DXCO3) is $9.95 with a high estimate of $10.50 and a low estimate of $9.50. The average target implies an upside of 18.88% from the current price of $8.37.
Based on GuruFocus estimates, the estimated GF Value for Dexco SA (BSP:DXCO3, Financial) in one year is $8.23, suggesting a downside of -1.67% from the current price of $8.37.
Based on the consensus recommendation from 6 brokerage firms, Dexco SA's (BSP:DXCO3, Financial) average brokerage recommendation is currently 1.7, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
